πŸ‡ΊπŸ‡Έ FDA
Patent

US 6552181

Basal cell carcinoma tumor supressor gene

expired A61KA61K38/00A61P

Quick answer

US patent 6552181 (Basal cell carcinoma tumor supressor gene) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/00, A61P, A61P35/00